ZA201303607B - Imidazole derivatives as pde 10a enzyme inhibitors - Google Patents

Imidazole derivatives as pde 10a enzyme inhibitors

Info

Publication number
ZA201303607B
ZA201303607B ZA2013/03607A ZA201303607A ZA201303607B ZA 201303607 B ZA201303607 B ZA 201303607B ZA 2013/03607 A ZA2013/03607 A ZA 2013/03607A ZA 201303607 A ZA201303607 A ZA 201303607A ZA 201303607 B ZA201303607 B ZA 201303607B
Authority
ZA
South Africa
Prior art keywords
pde
enzyme inhibitors
imidazole derivatives
imidazole
derivatives
Prior art date
Application number
ZA2013/03607A
Other languages
English (en)
Inventor
Jan Kehler
Jacob Nielsen
Mauro Marigo
John Paul Kilburn
Morten Langgard
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of ZA201303607B publication Critical patent/ZA201303607B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA2013/03607A 2010-11-19 2013-05-17 Imidazole derivatives as pde 10a enzyme inhibitors ZA201303607B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201001045 2010-11-19
PCT/DK2011/000136 WO2012065612A1 (en) 2010-11-19 2011-11-18 Imidazole derivatives as pde10a enzyme inhibitors

Publications (1)

Publication Number Publication Date
ZA201303607B true ZA201303607B (en) 2014-07-30

Family

ID=45217102

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2013/03607A ZA201303607B (en) 2010-11-19 2013-05-17 Imidazole derivatives as pde 10a enzyme inhibitors

Country Status (31)

Country Link
EP (1) EP2640731B9 (US20070167479A1-20070719-C00034.png)
JP (1) JP5937608B2 (US20070167479A1-20070719-C00034.png)
KR (1) KR101916487B1 (US20070167479A1-20070719-C00034.png)
CN (1) CN103328487B (US20070167479A1-20070719-C00034.png)
AP (1) AP3342A (US20070167479A1-20070719-C00034.png)
AR (1) AR083926A1 (US20070167479A1-20070719-C00034.png)
AU (1) AU2011331607B2 (US20070167479A1-20070719-C00034.png)
BR (1) BR112013012378A2 (US20070167479A1-20070719-C00034.png)
CA (1) CA2817663C (US20070167479A1-20070719-C00034.png)
CR (1) CR20130226A (US20070167479A1-20070719-C00034.png)
DK (1) DK2640731T3 (US20070167479A1-20070719-C00034.png)
EA (1) EA027082B1 (US20070167479A1-20070719-C00034.png)
EC (1) ECSP13012698A (US20070167479A1-20070719-C00034.png)
ES (1) ES2547090T3 (US20070167479A1-20070719-C00034.png)
GE (1) GEP20156346B (US20070167479A1-20070719-C00034.png)
GT (1) GT201300130A (US20070167479A1-20070719-C00034.png)
HU (1) HUE025596T2 (US20070167479A1-20070719-C00034.png)
JO (1) JO3089B1 (US20070167479A1-20070719-C00034.png)
ME (1) ME02193B (US20070167479A1-20070719-C00034.png)
MY (1) MY163327A (US20070167479A1-20070719-C00034.png)
NZ (1) NZ610353A (US20070167479A1-20070719-C00034.png)
PE (1) PE20141534A1 (US20070167479A1-20070719-C00034.png)
PL (1) PL2640731T3 (US20070167479A1-20070719-C00034.png)
PT (1) PT2640731E (US20070167479A1-20070719-C00034.png)
RS (1) RS54210B1 (US20070167479A1-20070719-C00034.png)
SG (1) SG190282A1 (US20070167479A1-20070719-C00034.png)
SI (1) SI2640731T1 (US20070167479A1-20070719-C00034.png)
TW (1) TWI541245B (US20070167479A1-20070719-C00034.png)
UA (1) UA112065C2 (US20070167479A1-20070719-C00034.png)
WO (1) WO2012065612A1 (US20070167479A1-20070719-C00034.png)
ZA (1) ZA201303607B (US20070167479A1-20070719-C00034.png)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8552045B2 (en) 2010-11-19 2013-10-08 H. Lundbeck A/S Tricyclic imidazole compounds as PDE10 inhibitors
EP3210984B1 (en) 2011-01-11 2019-06-19 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
WO2013045607A1 (en) * 2011-09-30 2013-04-04 H. Lundbeck A/S Quinazoline linked heteroaromatic tricycle derivatives as pde10a enzyme inhibitors
WO2013107856A1 (en) * 2012-01-20 2013-07-25 H. Lundbeck A/S Imidazole derivatives as pde10a enzyme inhibitors
NZ702239A (en) 2012-06-19 2017-01-27 Sunovion Pharmaceuticals Inc Heteroaryl compounds and methods of use thereof
CN103435617B (zh) * 2013-08-22 2016-04-27 南京华安药业有限公司 一种6,7-二氢-5H-吡咯并[1,2-a]咪唑-2-甲醛的合成方法
JO3627B1 (ar) 2015-04-30 2020-08-27 H Lundbeck As إيميدازو بيرازينونات على هيئة مثبطات pde1
TWI729109B (zh) 2016-04-12 2021-06-01 丹麥商H 朗德貝克公司 作爲PDE1抑制劑的1,5-二氫-4H-吡唑并[3,4-d]嘧啶-4-酮和1,5-二氫-4H-吡唑并[4,3-c]吡啶-4-酮
CN109843884B (zh) 2016-10-18 2022-03-04 H.隆德贝克有限公司 作为pde1抑制剂的咪唑并吡嗪酮、吡唑并嘧啶酮和吡唑并吡啶酮
CA3041595A1 (en) 2016-10-28 2018-05-03 H. Lundbeck A/S Combination treatments comprising administration of imidazopyrazinones
EP3532064B1 (en) 2016-10-28 2020-07-29 H. Lundbeck A/S Combination treatments comprising imidazopyrazinones for the treatment of psychiatric and/or cognitive disorders
TW202031250A (zh) 2018-11-06 2020-09-01 丹麥商H 朗德貝克公司 用於治療負性症狀和認知損傷之pde10a抑制劑
CN109776527A (zh) * 2019-02-21 2019-05-21 药雅科技(上海)有限公司 一种5-溴-7-氮杂吲哚的合成方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8307865D0 (en) 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
US5571775A (en) 1994-07-11 1996-11-05 Dowelanco N-aryl[1,2,4]triazolo[1,5-a]pyridine-2-sulfonamide herbicides
US20030032579A1 (en) 2001-04-20 2003-02-13 Pfizer Inc. Therapeutic use of selective PDE10 inhibitors
IL149106A0 (en) 2001-04-20 2002-11-10 Pfizer Prod Inc Therapeutic use of selective pde10 inhibitors
UA86591C2 (ru) 2003-06-30 2009-05-12 Алтана Фарма Аг Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе
CA2530114A1 (en) 2003-06-30 2005-01-13 Altana Pharma Ag Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors
WO2005012485A2 (en) 2003-07-31 2005-02-10 Bayer Pharmaceuticals Corporation Methods for treating diabetes and related disorders using pde10a inhibitors
WO2005082883A2 (en) 2004-02-18 2005-09-09 Pfizer Products Inc. Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline
CA2568929A1 (en) 2004-06-07 2005-12-22 Pfizer Products Inc. Phosphodiesterase 10 inhibition as treatment for obesity-related and metabolic syndrome-related conditions
US20060019975A1 (en) 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
WO2006028957A1 (en) 2004-09-03 2006-03-16 Memory Pharmaceuticals Corporation 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms
TWI501965B (zh) * 2008-06-20 2015-10-01 Lundbeck & Co As H 作為pde10a酵素抑制劑之新穎苯基咪唑衍生物
UA102693C2 (ru) * 2008-06-20 2013-08-12 Х. Луннбек А/С Производные фенилимидазола как ингибиторы фермента pde10a
US8133897B2 (en) * 2008-06-20 2012-03-13 H. Lundbeck A/S Phenylimidazole derivatives as PDE10A enzyme inhibitors
TW201200516A (en) * 2009-12-17 2012-01-01 Lundbeck & Co As H Phenylimidazole derivatives comprising an ethynylene linker as PDE10A enzyme inhibitors
TWI481607B (zh) * 2009-12-17 2015-04-21 Lundbeck & Co As H 作為pde10a酵素抑制劑的2-芳基咪唑衍生物
TWI485151B (zh) * 2009-12-17 2015-05-21 Lundbeck & Co As H 作為pde10a酵素抑制劑之雜芳香族苯基咪唑衍生物

Also Published As

Publication number Publication date
AU2011331607B2 (en) 2016-05-19
CA2817663A1 (en) 2012-05-24
RS54210B1 (en) 2015-12-31
BR112013012378A2 (pt) 2016-08-30
SG190282A1 (en) 2013-06-28
ECSP13012698A (es) 2013-08-30
WO2012065612A1 (en) 2012-05-24
EP2640731A1 (en) 2013-09-25
PT2640731E (pt) 2015-10-13
EA027082B1 (ru) 2017-06-30
CN103328487A (zh) 2013-09-25
AP2013006928A0 (en) 2013-06-30
KR101916487B1 (ko) 2018-11-07
GEP20156346B (en) 2015-08-10
MY163327A (en) 2017-09-15
ME02193B (me) 2016-02-20
AR083926A1 (es) 2013-04-10
CN103328487B (zh) 2015-11-25
EA201390741A1 (ru) 2013-11-29
GT201300130A (es) 2015-01-16
HUE025596T2 (en) 2016-03-29
CR20130226A (es) 2013-09-03
JP5937608B2 (ja) 2016-06-22
TW201300391A (zh) 2013-01-01
EP2640731B1 (en) 2015-07-08
AU2011331607A1 (en) 2013-05-30
TWI541245B (zh) 2016-07-11
JP2013542963A (ja) 2013-11-28
SI2640731T1 (sl) 2015-10-30
DK2640731T3 (en) 2015-08-31
ES2547090T3 (es) 2015-10-01
PL2640731T3 (pl) 2015-11-30
PE20141534A1 (es) 2014-11-16
NZ610353A (en) 2015-01-30
UA112065C2 (uk) 2016-07-25
EP2640731B9 (en) 2015-11-25
AP3342A (en) 2015-07-31
JO3089B1 (ar) 2017-03-15
CA2817663C (en) 2020-04-28
KR20140009192A (ko) 2014-01-22

Similar Documents

Publication Publication Date Title
ZA201303607B (en) Imidazole derivatives as pde 10a enzyme inhibitors
IL221823A (en) Pipridine-4-Il-Aztidine Derivatives as Jack 1 Suppressors
ZA201301951B (en) Benzimidazole derivatives as p13 kinase inhibitors
HK1177739A1 (en) 2-arylimidazole derivatives as pde10a enzyme inhibitors pde10a 2-
HK1177745A1 (en) Heteroaromatic aryl triazole derivatives as pde10a enzyme inhibitors pde10a
HK1177208A1 (en) Heteroaromatic phenylimidazole derivatives as pde10a enzyme inhibitors pde10a
EP2300438A4 (en) IMIDAZOLE DERIVATIVES AS FAAH INHIBITORS
SI3070091T1 (sl) Derivati benzodioksola kot zaviralci fosfodiesteraze
PL2588457T3 (pl) Pochodne pirazolochinolinowe jako inhibitory dna-pk
HRP20150939T1 (en) Pyrazole derivatives useful as aldosterone synthase inhibitors
HK1202861A1 (en) Quinoline derivatives as pde10a enzyme inhibitors pde10a
HK1189593A1 (en) Imidazole derivatives as pde10a enzyme inhibitors pde10a